Simultaneous Determination of Methocarbamol and Paracetamol in the Presence of Three Related Substances by Ultra Performance Liquid Chromatography

Author(s): Yanjuan Zheng, Qiushi Peng, Rui Dong*, Tingyu Chen, Yi Bao, Qianrong Peng*, Min Yang*.

Journal Name: Current Pharmaceutical Analysis

Volume 15 , Issue 5 , 2019

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

Introduction: A rapid, and accurate Ultra Performance Liquid Chromatography (UPLC) method was developed to simultaneously analyze Methocarbamol, Paracetamol and the related substances.

Materials and Methods: Waters ACQUITY UPLC® BEH Phenyl C18 column was used in conjunction with UV detection at 225nm. Gradient elution with 0.05M, pH 6 phosphate buffer and acetonitrile flow at 0.3mL /min rate were used to separate the substances. The retention times for 4-Aminopheno, Paracetamol, Guaifenesin, Methocarbamol, and 4-Chloroacetanilide were 1.319 minute, 2.224 minute, 4.467 minute, 4.769 minute and 5.433 minute respectively. The concentration was linear in the range of 2-100 µg/ml for Methocarbamol, and 1-100 µg/mL for Paracetamol. The percentage recoveries were between 99.28±1.23% to 100.57±0.99% for Methocarbamol, and between 99.08±1.23% to 101.23±1.39% for Paracetamol.

Results and Discussion: The validated optimal protocol is robust and accurate for simultaneous analysis of Methocarbamol, Paracetamol and the related substances, applicable for bulk powder as well as pharmaceutical formulation.

Conclusion: In this paper, a highly sensitive, accurate, and precise UPLC method with UV-Vis detection was developed and validated for quality control of MET and PAR in bulk as well as in pharmaceutical preparations.

Keywords: Methocarbamol, guaifenesin, paracetamol, 4-aminophenol, 4-chloroacetanilide, UPLC.

[1]
Krishnaiah, C.; Reddy, A.R.; Kumar, R.; Mukkanti, K. Stability-indicating UPLC method for determination of Valsartan and their degradation products in active pharmaceutical ingredient and pharmaceutical dosage forms. J. Pharm. Biomed. Anal., 2010, 53(3), 483-489.
[2]
Krishnaiah, C.; Murthy, V.M.; Kumar, R.; Mukkanti, K. Development of a stability-indicating UPLC method for determining olanzapine and its associated degradation products present in active pharmaceutical ingredients and pharmaceutical dosage forms. J. Pharm. Biomed. Anal., 2011, 54(4), 667-673.
[3]
Makwana, S.; Patel, M.; Prajapati, D.; Shingala, C.; Upadhyay, J.; Shah, A. Validated Stability Indicating Chromatographic Method for the Simultaneous Estimation of Camylofin with NSAID Drugs and a New Approach of Method Transfer from Classical HPLC to a Modern UPLC Instrument. Chromatogr. Res. Int., 2016, 4, 1-7.
[4]
Vallapragada, V.V.; Inti, G.; Vidiyala, S.R.; Jadi, S. Validated UPLC method for determination of unbound bile acids in colesevelam HCl tablets. J. Chromatogr. Sci., 2015, 53(1), 154-160.
[5]
Lv, Y.; Zhang, X.; Liang, X.; Liu, X.; Dai, W.; Yan, W.; Zhang, W. Characterization of the constituents in rat biological fluids after oral administration of Fufang Danshen tablets by ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry. J. Pharm. Biomed. Anal., 2010, 52(1), 155-159.
[6]
Wen-Ping, W.; Liu, N.; Kang, Q.; Pei-Pei, D.; Lan, Y.; Bo-Chen, Z.; Yan-Yan, C.; Zhang, Q.; Li, H.; Ye-Wen, Z.; Wu, Q. Simultaneous determination by UPLC-MS/MS of seven bioactive compounds in rat plasma after oral administration of Ginkgo biloba tablets: application to a pharmacokinetic study. J. Zhejiang Univ. Sci. B, 2014, 15(11), 929.
[7]
Ram, V.; Kher, G.; Dubal, K.; Dodiya, B.; Joshi, H. Development and validation of a stability indicating UPLC method for determination of ticlopidine hydrochloride in its tablet formulation. SPJ, 2011, 19(3), 159-164.
[8]
Eid, M.A.; Yusof, N.A.; Faruq, M.; Abdullah, J.; Sulaiman, Y. Quantitative measurement of amoxicillin in Ibuprofen tablets using UPLC. Measurement, 2016, 93, 465-472.
[9]
Srinivasu, T.; Rao, B.N.; Annapurna, M.M.; Chandrashekhar, T.G. RP-UPLC method for combinational assay of lornoxicam and paracetamol in combined tablet dosage form. IJPSR.,, 2012, 3 (4)
[10]
Trivedi, H.K.; Patel, M.C. Development and validation of a stability-indicating RP-UPLC method for determination of rosuvastatin and related substances in pharmaceutical dosage form. Sci. Pharm., 2012, 80(2), 393-406.
[11]
Miranda, T.A.; Silva, P.H.R.; Pianetti, G.A.; César, I.C. Simultaneous quantitation of chloroquine and primaquine by UPLC-DAD and comparison with a HPLC-DAD method. Malar. J., 2015, 14(1), 1-7.
[12]
Sunil, S.; Nisha, C.; Jyoti, R. Inamullah.; Surabhi, S.; Kumar, Y.A.; Hemendra, G.; Shashank, C.; Kumar, A.V. Validated RPUPLC Method Development for Estimation of Lansoprazole in Tablet Dosage Form. IJPSDR.,, 2013, 5(3)
[13]
Abdelaleem, E.A.; Abdelwahab, N.S. Validated stability indicating RP-HPLC method for determination of paracetamol, methocarbamol and their related substances. Anal. Methods, 2013, 5(2), 541-545.
[14]
Parr, J.S.; Khalifah, R.G. Inhibition of carbonic anhydrases I and II by N-unsubstituted carbamate esters. J. Biol. Chem., 1992, 267(35), 25044-25050.
[15]
The United States Pharmacopeia (USP 30).; National Formulary (NF 25).; Rockville, MD,. , 2007.
[16]
Uematsu, T.; Nakano, M.; Kosuge, K.; Nagai, A.; Sato, A.; Nakashima, M. Pharmacokinetic properties of a novel gastric proton pump inhibitor, (+/-)-2-[(4-methoxy-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-yl)sulfinyl]-1H-benzimidazole sodium salt, in healthy subjects. J. Pharm. Sci-US., 1994, 83(10), 1407-1411.
[17]
Lee, E.H.P.T. A peer-reviewed journal for formulary management. ASHP, 2011, 36(3), 159.
[18]
Hinz, B.; Cheremina, O.; Brune, K. Acetaminophen (paracetamol) is a selective cyclooxygenase-2 inhibitor in man. FASEB J., 2008, 22(2), 383-390.
[19]
Travis, A.S. Manufacture and uses of the anilines: A vast array of processes and products". In Zvi Rappoport Chem. Anilines Part 1. Wiley, P, 2007. 764.
[20]
Bloomfield, M.S. A sensitive and rapid assay for 4-aminophenol in paracetamol drug and tablet formulation, by flow injection analysis with spectrophotometric detection. Talanta, 2002, 58(6), 1301-1310.


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 15
ISSUE: 5
Year: 2019
Page: [505 - 510]
Pages: 6
DOI: 10.2174/1573412914666180702150357
Price: $58

Article Metrics

PDF: 34
HTML: 7